Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
56,354,518
-
Share change
-
+1,597,119
-
Total reported value
-
$4,173,671,314
-
Put/Call ratio
-
70%
-
Price per share
-
$74.09
-
Number of holders
-
262
-
Value change
-
+$183,614,577
-
Number of buys
-
126
-
Number of sells
-
139
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2018
As of 31 Mar 2018,
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,354,518 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FRED ALGER MANAGEMENT INC, JENNISON ASSOCIATES LLC, GILDER GAGNON HOWE & CO LLC, DEUTSCHE BANK AG\, and EAGLE ASSET MANAGEMENT INC.
This page lists
262
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.